Metazym
From Self-sufficiency
Metazym is being trialed in Patients with late infantile Metachromatic Leukodystrophy[1]. The drug produced by Shire costs in the vicinity of US$90,000 per month [2]. A company spokesman notes that the drug will not be on the market until at least 2012
